满地(01400.HK)急弹2.5倍曾逼近52周高位 拟进行口罩原材料及成品生产
满地科技(01400.HK)拟计划进行口罩原材料及成品之生产,以应对内地当前新冠肺炎疫情,该股今早一度飙升4.8倍至0.5元,接近52周高位0.52元遇阻,弹幅急速收窄至2.5倍,报0.3元,股价重越牛熊线(0.244元),一向稀疏成交激增至1,770万股,创逾七个月高。
满地科技主要从事纺织业务,公司表现,面对当前新冠肺炎疫情,医疗防护物资严重短缺的局面,公司向应当地政府的号召,将积极考虑组织现有之生产资源,改造和添加口罩生产设备,在湖北及福建两大纺织生产基地,拟计划进行口罩原材料及成品之生产。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.